TABLE IV.
Responses of prostate cancer patients to costs incurred, according to proportion of income consumed by out-of pocket (oop) costs
| Question |
oop cost level [n (%)]
|
p Valueb | |||
|---|---|---|---|---|---|
| Overall | 0% 0.01%–7.49% | ≥7.50% | |||
| Use any drug-related strategy | |||||
| No | 156 (91.8) | 88 (96.7) | 47 (90.4) | 21 (77.8) | 0.007c |
| Yes | 14 (8.2) | 3 (3.3) | 5 (9.6) | 6 (22.2) | |
| Use any appointment-related strategy | |||||
| No | 164 (96.5) | 90 (98.9) | 50 (96.2) | 24 (88.9) | 0.046c |
| Yes | 6 (3.5) | 1 (1.1) | 2 (3.8) | 3 (11.1) | |
| oop costs influenced treatment decisions | |||||
| Disagree | 116 (92.8) | 49 (94.2) | 47 (95.9) | 20 (83.3) | 0.129 |
| Agree | 9 (7.2) | 3 (5.8) | 2 (4.1) | 4 (16.7) | |
| Doctor aware of my oop costs | |||||
| Disagree | 84 (73.0) | 32 (68.1) | 38 (32.6) | 14 (63.6) | 0.156 |
| Agree | 31 (27.0) | 15 (31.9) | 8 (17.4) | 8 (37.4) | |
| Doctor takes costs into account | |||||
| Disagree | 99 (86.8) | 36 (80.0) | 44 (93.6) | 19 (86.4) | 0.154 |
| Agree | 15 (13.2) | 9 (20.0) | 3 (6.4) | 3 (13.6) | |
| Cancer costs create a lot of stress | |||||
| Disagree | 88 (72.7) | 37 (77.1) | 40 (83.3) | 11 (44.0) | 0.001d |
| Agree | 33 (27.3) | 11 (22.9) | 8 (16.7) | 14 (56.0) | |
| Cancer costs more stressful than other things | |||||
| Disagree | 96 (78.7) | 40 (81.6) | 43 (89.6) | 13 (52.0) | 0.001d |
| Agree | 26 (21.3) | 9 (18.4) | 5 (10.4) | 12 (48.0) | |
| Trouble paying for my cancer costs | |||||
| Disagree | 105 (87.5) | 45 (93.8) | 43 (89.6) | 17 (70.8) | 0.018d |
| Agree | 15 (12.5) | 3 (6.2) | 5 (10.4) | 7 (29.2) | |
| Aware of assistance programs | |||||
| Disagree | 88 (72.7) | 36 (70.6) | 38 (79.2) | 14 (63.6) | 0.361 |
| Agree | 33 (27.3) | 15 (29.4) | 10 (20.8) | 8 (36.4) | |
| Assistance programs well advertised | |||||
| Disagree | 115 (87.1) | 8 (13.3) | 6 (12.8) | 3 (12.0) | 0.986 |
| Agree | 17 (12.9) | 52 (86.7) | 41 (86.7) | 22 (88.0) | |
a
Item responses may add to less than 170 because of missing data.
b
Based on chi-square tests comparing the three levels of costs.
c
Post hoc tests show significant differences between the 0% and ≥7.50% groups, but no other differences.
d
Post hoc tests show significant differences between the ≥7.50% group and the 0% and 0.01%–7.49% groups, but no other differences.